rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
43-44
|
pubmed:dateCreated |
2003-2-14
|
pubmed:abstractText |
Prognostic classification of congestive heart failure (CHF) is difficult and only possible with the help of additional diagnostic tools. B-type natriuretic peptide (BNP) has been used as a diagnostic and prognostic marker for patients (pts) with CHF. In this study, the clinical value of BNP for stratification and treatment of pts with CHF was evaluated.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1424-7860
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
14
|
pubmed:volume |
132
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
623-8
|
pubmed:dateRevised |
2011-2-15
|
pubmed:meshHeading |
pubmed-meshheading:12587046-Adult,
pubmed-meshheading:12587046-Aged,
pubmed-meshheading:12587046-Aged, 80 and over,
pubmed-meshheading:12587046-Atrial Natriuretic Factor,
pubmed-meshheading:12587046-Cardiotonic Agents,
pubmed-meshheading:12587046-Cohort Studies,
pubmed-meshheading:12587046-Exercise Test,
pubmed-meshheading:12587046-Follow-Up Studies,
pubmed-meshheading:12587046-Heart Failure,
pubmed-meshheading:12587046-Hemodynamics,
pubmed-meshheading:12587046-Humans,
pubmed-meshheading:12587046-Middle Aged,
pubmed-meshheading:12587046-Natriuretic Peptide, Brain,
pubmed-meshheading:12587046-Outcome Assessment (Health Care),
pubmed-meshheading:12587046-Point-of-Care Systems,
pubmed-meshheading:12587046-Reproducibility of Results,
pubmed-meshheading:12587046-Risk Assessment,
pubmed-meshheading:12587046-Severity of Illness Index
|
pubmed:year |
2002
|
pubmed:articleTitle |
B-type natriuretic peptide for diagnosis and treatment of congestive heart failure.
|
pubmed:affiliation |
Swiss Cardiovascular Center, Institute of Clinical Chemistry, University Hospital, Bern, Switzerland.
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|